Prognostic significance of HLA-DR antigen in serous ovarian tumors

Clinical and Experimental Medicine

Volumn 3, Issue 2, 2003, Pages 113-118

  Tamiolakis, D ^a   Kotini, A ^b   Venizelos, J ^c   Jivannakis, T ^d   Simopoulos, P ^b   Papadopoulos, N ^b  

^a UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c Ippokration Hospital Thessaloniki   (Greece)

^d General Hospital of Drama   (Greece)

Author keywords

HLA DR CD4; Serous borderline ovarian tumors; Serous ovarian carcinoma; Serous ovarian cystadenoma

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYSTADENOMA; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

ANTIGENS, CD4; CYSTADENOMA, SEROUS; FEMALE; HLA-DR ANTIGENS; HUMANS; OVARIAN NEOPLASMS; PROGNOSIS;

FALLOPIA;

EID: 0141918861     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-003-0013-0     Document Type: Article

References (44)

1. Frelinger JA (1983) Tissue distribution and cellular expression of Ia antigens. In: Ferrone S, David CS (eds) Ia antigens I. Mice. CRC Press, Boca Raton
2. Lafuse WP, David CS (1984) Ia antigens. Genes, molecules, and function. Transplantation 38:443-453
3. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ (1984) The detailed distribution of MHC class II antigens in normal human organs. Transplantation 38:293-298
4. Klein J, Figuerou F, Nagy A (1983) Genetics of the major histocompatibility complex: the final act. Annu Rev of Immunol 1:119-142
5. Steinmetz M, Hood L (1983) Genes of the major histocompatibility complex in mouse and man. Science 222:727-733
6. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al (1999) Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 163: 6718-6724
7. Eisenhauer PB, Harwig SS, Lehrer RI (1992) Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun 60:3556-3565
8. Andoh A, Fujiyama Y, Bamba T, Hosoda S (1993) Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 151:4239-4247
9. Hershberg RM, Framson PE, Cho DH, Lee LY, Kovats S, Beitz J, et al (1997) Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest 100:204-215
10. Bland PW, Warren LG (1986) Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology 58:1-7
11. Kelley VR, Singer GG (1993) The antigen presentation function of renal tubular epithelial cells. Exp Nephrol 1:102-111
12. Nickoloff BJ, Turka LA (1994) Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 15: 464-469
13. Savage CO, Brooks CJ, Harcourt GC, Picard JK, King W, Sansom DM, et al (1995) Human vascular endothelial cells process and present autoantigen to human T cell lines. Int Immunol 7:471-479
14. Berin MC, Kiliaan AJ, Yang PC, Groot JA, Taminiau JA, Perdue MH (1997) Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 113:856-864
15. Dickinson BL, Badizadegan K, Wu Z, Ahouse JC, Zhu X, Simister NE, et al (1999) Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest 104:903-911
16. Israel EJ, Taylor S, Wu Z, Mizoguchi E, Blumberg RS, Bhan A, et al (1997) Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92:69-74
17. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, Guyre PM, et al (1997) Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 38:350-359
18. Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W, et al (1997) Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 61:427-435
19. Poppe WA, Drijkoningen M, Ide PS, Lauweryns JM, Van Assche FA (1998) Lymphocytes and dendritic cells in the normal uterine cervix. An immunohistochemical study. Eur J Obstet Gynecol Reprod Biol 81:277-282
20. Kaiserlian D, Vidal K, Revillard JP (1989) Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur J Immunol 19:1513-1516
21. Kaiserlian D (1999) Epithelial cells in antigen. Sampling and presentation in mucosal tissues. Curr Top Microbiol Immunol 236:55-78
22. Wira CR, Rossoll RM (1995) Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 136:4526-4534
23. Wira CR, Rossoll RM (1995) Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 84:505-508
24. Dammrich J, Muller-Hermelink HK, Mattner A, Buchwald J, Ziffer S (1990) Histocompatibillity antigen expression in pulmonary carcinomas as indication of differentiation and of special subtypes. Cancer 65:1942-1954
25. Redondo M, Concha A, Oldiviela R, Cueto A, Gonzalez A, Garrido F, et al (1991) Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters. Cancer Res 51:4948-4954
26. Pantel K, Schlimok G, Kutter D, Schaller G, Genz T, Wiebecke B, et al (1991) Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res 51:4712-4715
27. Goepel JR, Rees RC, Rogers K, Stoddard CJ, Thomas WEG, Shepherd L (1991) Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma. Br J Cancer 64:880-883
28. van Duinen SG, Ruiter DJ, Broecker EB, Velde EA van der, Sorg C, Welvaart K, et al (1988) Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res 48:1019-1025
29. Scupoli MT, Sartoris S, Tosi G, Ennas MG, Nicolis M, Cestari T, et al (1996) Expression of MHC class I and II antigens in pancreatic adenocarcinomas. Tissue Antigens 48:301-311
30. Brunner CA, Gokel JM, Riethmullerand G, Johnson JP (1991) Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis. Eur J Cancer 27:411-416
31. Esteban F, Concha A, Huelin C, Perez-Ayala M, Pedrinaci S, Ruiz-Cabello F, et al (1989) Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx. Int J Cancer 43:436-442
32. Natali P, Bigotti A, Cavalieri R, Nicotra MR, Tecce R, Manfredi D, et al (1986) Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin. Hum Immunol 15:220-233
33. Connor ME, Stern PL (1990) Loss of MHC class-I expression in cervical carcinomas. Int J Cancer 46:1029-1034
34. Stein B, Momburg F, Schwarz V, Schlag P, Moldenhauer G, Muller P (1988) Reduction or loss of HLA-A, B, C antigens in colorectal carcinoma appears not to influence survival. Br J Cancer 57:364-368
35. Wintzer HO, Benzing M, Kleist S von (1990) Lacking prognostic significance of 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas. Br J Cancer 62:289-295
36. Ghosh AK, Moore M, Street AJ, Howat JMT, Schofield PF (1986) Expression of HLA-D sub-region products on human colorectal carcinoma. Int J Cancer 38:459-464
37. Kamma H, Yazawa T, Ogata T, Horiguchi H, Iijima T (1991) Expression of MHC class II antigens in human lung cancer cells. Virchows Arch B Cell Pathol 60:407-412
38. Dammrich J, Buchwald J, Papadopoulos T, Muller-Hermelink HK (1991) Special subtypes of pulmonary adenocarcinomas indicated by different tumor cell HLA-expression and stromal infiltrates. Virchows Arch B Cell Pathol 61:9-18
39. Kabawat SE, Bast RC Jr, Welch WR, Knapp RC, Bhan AK (1983) Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms. Int J Cancer 32:547-554
40. Van Niekerk CC, Ramaekers FC, Hanselaar AG, Aldeweireldt J, Poels LG (1993) Changes in expression of differentiation markers between normal ovarian cells and derived tumors. Am J Pathol 142:157-177
41. Vaccarello L, Kanbour A, Kanbour-Shakir A, Whiteside TL (1993) Tumor-infiltrating lymphocytes from ovarian tumors of low malignant potential. Int J Gynecol Pathol 12:41-50
42. Nijman HW, Diest PJ van, Poort-Keesom RJ, Mensdorff-Pouilly S von, Verstraeten RA, Kummer A, Meijer CJ, Melief CJ, Hilgers J, Kenemans P (2001) T cell infiltration and MHC I and II expression in the presence of tumor antigens: an immunohistochemical study in patients with serous epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 94:114-120
43. Dadmarz RD, Ordoubadi A, Mixon A, Thompson CO, Barracchini KC, Hijazi YM, Steller MA, Rosenberg SA, Schwartzentruber DJ (1996) Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an mhc class II - restricted fashion. Cancer J Sci Am 2:263
44. Di Bello M, Lucchini V, Chiari S, Colleoni R, Colombo N, Mantovani A, Allavena P (1988) DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative response. Cancer Immunol Immunother 27:63-68